ConductScience.org, home

Paper9687334

Microfabricated microneedles: a novel approach to transdermal drug delivery.

Henry S and 3 others. J Pharm Sci, 1998. Cited by 603 papers, by iCite.

Cite this record

ConductScience Library. Microfabricated microneedles: a novel approach to transdermal drug delivery. Papers, record 9687334. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9687334

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Microfabricated microneedles: a novel approach to transdermal drug delivery.
PubMed
Journal
J Pharm Sci
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
603
iCite
Relative citation ratio, by iCite
16.8
iCite
Revised in PubMed
2014-11-20
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Henry SS
2McAllister DVD V
3Allen MGM G
4Prausnitz MRM R

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Administration, CutaneousMajor topic
NeedlesMajor topic
Fluoresceins
Fluorescent Dyes
Humans
In Vitro Techniques
Microinjections
Microscopy, Electron, Scanning

Source PubMed

Download CSV of topics

Cited by298

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 603 citations.

PMIDTitleJournalYearIn PapersSource
42872141Hydrogel microneedles for chronic wound microenvironment remodeling: from drug delivery to intelligent treatment.Burns Trauma2026https://conductscience.org/library/papers/42872141PubMed
42786286Localized immunotherapy via dissolving microneedles for the prevention of breast cancer recurrence.Drug Deliv Transl Res2026https://conductscience.org/library/papers/42786286PubMed
42683333Smart micro/nanoneedles for gene delivery.Iran J Basic Med Sci2026https://conductscience.org/library/papers/42683333PubMed
42657113Hydrogel microneedles functioning in pathological surroundings: where soft materials overcome hard scars.Mater Today Bio2026https://conductscience.org/library/papers/42657113PubMed
42654043Vacuum-Assisted Microneedle Platforms for Dermal Interstitial Fluid Sampling.Pharmaceutics2026https://conductscience.org/library/papers/42654043PubMed
42634960Driving Drugs Deeper: Force-Driven Microneedle Systems for Active Therapy and Their Road Towards Clinical Implementation.Small2026https://conductscience.org/library/papers/42634960PubMed
42576754[Oral mucosal administration].Hua Xi Kou Qiang Yi Xue Za Zhi2026https://conductscience.org/library/papers/42576754PubMed
42487093Fucoidan-based microneedle patch for delivery of IGF1-loaded exosomes in diabetic wound therapy.Drug Deliv Transl Res2026https://conductscience.org/library/papers/42487093PubMed
42483405Evolution of 3D-Printed Microneedles toward Closed-Loop Theranostic Platforms.Research (Wash D C)2026https://conductscience.org/library/papers/42483405PubMed
42356986Biomimetic Material Selection for Therapeutic Microneedles: An Analytic Hierarchy Process-Based Multi-Criteria Evaluation.Polymers (Basel)2026https://conductscience.org/library/papers/42356986PubMed
42141238In vitro Evaluation of Hydroxypropyl-β-cyclodextrin Effects on Rhein Flux Across Microneedle-pretreated Skin.AAPS PharmSciTech2026https://conductscience.org/library/papers/42141238PubMed
42039282Advances of microneedle technology for the treatment of autoimmune diseases.Acta Pharm Sin B2026https://conductscience.org/library/papers/42039282PubMed
42026352Emerging and Prospective Engineering Technologies Enabling Microneedle Based Vaccine Therapeutics.AAPS PharmSciTech2026https://conductscience.org/library/papers/42026352PubMed
42020839
Development of poly(vinyl alcohol)/poly(N-vinyl caprolactam)-based hydrogel-forming microneedle for transdermal delivery of captopril: fabrication, characterization and in vivo antihypertensive activity test.
Drug Deliv Transl Res2026https://conductscience.org/library/papers/42020839PubMed
42009974Advances in veterinary drug and vaccine delivery: from conventional delivery methods to innovative transdermal approaches.Drug Deliv Transl Res2026https://conductscience.org/library/papers/42009974PubMed
41953719Microneedle-based theranostics for melanoma: Advances and outlook.Mater Today Bio2026https://conductscience.org/library/papers/41953719PubMed
41694095Biphasic dissolving microneedles with cyclodextrin inclusion complexes for enhanced delivery of poorly soluble drugs.RSC Adv2026https://conductscience.org/library/papers/41694095PubMed
41572720Advancements and challenges in ophthalmic microneedles to treat eye diseases.Drug Deliv2026https://conductscience.org/library/papers/41572720PubMed
414761713D-printed barbed microneedle electrodes for biosensing and drug delivery in wound management.Microsyst Nanoeng2026https://conductscience.org/library/papers/41476171PubMed
41471093Systematic Development and Characterization of Enzyme-Free, Borax-Crosslinked Microneedles for Glucose-Responsive Insulin Delivery and In Vivo Glycemic Mitigation.Pharmaceutics2025https://conductscience.org/library/papers/41471093PubMed

See all 298 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9687334

GET https://conductscience.org/api/papers/v1/9687334/cited_by?page=2